@article{ref1,
title="Controversy exists in the use of selective serotonin reuptake inhibitors in children and adolescents",
journal="Drugs and therapy perspectives",
year="2005",
author="Mithoowani, F.",
volume="21",
number="5",
pages="20-23",
abstract="Until recently, selective serotonin reuptake inhibitors (SSRIS) were widely prescribed off-label for the treatment of depression and other psychiatric conditions in children and adolescents. However, the UK Committee on Safety of Medicines and the US FDA have recommended caution in the use of SSRIs in this patient group because of an increased risk of suicidality. However, data supporting this warning appear to be equivocal.<p /><p>Language: en</p>",
language="en",
issn="1172-0360",
doi="10.2165/00042310-200521050-00007",
url="http://dx.doi.org/10.2165/00042310-200521050-00007"
}